1. Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms
- Author
-
Massironi, S, Franchina, M, Ippolito, D, Elisei, F, Falco, O, Maino, C, Pagni, F, Elvevi, A, Guerra, L, Invernizzi, P, Massironi S., Franchina M., Ippolito D., Elisei F., Falco O., Maino C., Pagni F., Elvevi A., Guerra L., Invernizzi P., Massironi, S, Franchina, M, Ippolito, D, Elisei, F, Falco, O, Maino, C, Pagni, F, Elvevi, A, Guerra, L, Invernizzi, P, Massironi S., Franchina M., Ippolito D., Elisei F., Falco O., Maino C., Pagni F., Elvevi A., Guerra L., and Invernizzi P. more...
- Abstract
Introduction: Neuroendocrine neoplasms (NENs) represent a complex group of tumors arising from neuroendocrine cells, characterized by heterogeneous behavior and challenging diagnostics. Despite advancements in medical technology, NENs present a major challenge in early detection, often leading to delayed diagnosis and variable outcomes. This review aims to provide an in-depth analysis of current diagnostic methods as well as the evolving and future directions of diagnostic strategies for NENs. Area covered: The review extensively covers the evolution of diagnostic tools for NENs, from traditional imaging and biochemical tests to advanced genomic profiling and next-generation sequencing. The emerging role of technologies such as artificial intelligence, machine learning, and liquid biopsies could improve diagnostic precision, as could the integration of imaging modalities such as positron emission tomography (PET)/magnetic resonance imaging (MRI) hybrids and innovative radiotracers. Expert opinion: Despite progress, there is still a significant gap in the early diagnosis of NENs. Bridging this diagnostic gap and integrating advanced technologies and precision medicine are crucial to improving patient outcomes. However, challenges such as low clinical awareness, limited possibility of noninvasive diagnostic tools and funding limitations for rare diseases like NENs are acknowledged. more...
- Published
- 2024